Achilles Therapeutics (STU:698) Ending Cash Position : €0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Ending Cash Position?

Achilles Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2024 was €0.00 Mil.

Achilles Therapeutics's quarterly Ending Cash Position increased from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€103.37 Mil) but then declined from Mar. 2024 (€103.37 Mil) to Jun. 2024 (€0.00 Mil).

Achilles Therapeutics's annual Ending Cash Position declined from Dec. 2021 (€235.72 Mil) to Dec. 2022 (€163.66 Mil) and declined from Dec. 2022 (€163.66 Mil) to Dec. 2023 (€120.65 Mil).

Achilles Therapeutics Ending Cash Position Historical Data

The historical data trend for Achilles Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achilles Therapeutics Ending Cash Position Chart

Achilles Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

87.84

146.19

235.72

163.66

120.65

Achilles Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Ending Cash Position	Get a 7-Day Free Trial														-	-	-	103.37	-

Achilles Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Achilles Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	158.983	+	-38.331
	=	120.65

Achilles Therapeutics's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Achilles Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Achilles Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Achilles Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (STU:698) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ACHL:USA 698:Germany

Address

245 Hammersmith Road, London, GBR, W6 8PW

Website

https://www.achillestx.com

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Achilles Therapeutics Headlines

No Headlines